/
Corporate Information We were incorporated in California in 1982, became a public company in 1994, and were reincorporated in Delaware in January 2012. Our principal executive offices are located at 14185 Dallas Parkway, Suite 300, Dallas, Texas 75254 and our telephone number is (972) 391-5000.
$27.61
$0.68 (-2.40%)
EOD Jul 17, 2026
Margins and capital returns are both well above average: 36.51% operating margin, ROIC at 15.94%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 9.7%, steady but not accelerating.
Even for strong businesses, today's 17x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
17.3x earnings, 19.4x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$4.64B
▲ +9.7% YoY
Net Income (TTM)
$1.55B
▲ +13.9% YoY
Op. Margin
36.57%
▼ -0.6pp YoY
ROIC
14.27%
▼ -1.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$1.34B
▲ +28.0% YoY
Op. Cash Flow (TTM)
$1.69B
▲ +22.2% YoY
Net Debt
-$3.35B
Net Cash Position
Cash & Equiv.
$3.35B
5Y CAGR: +16.1%
5Y CAGR: +30.4%
Continue Research
At a P/E of 17.3 and a price-to-free-cash-flow of 19.4, Copart (CPRT) trades below a two-stage DCF intrinsic value of about $75.26 per share, so at $27.61 the stock looks undervalued (172.6% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Copart scores 74/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $75.26 per share for CPRT, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $56.45. At today's $27.61, that puts the stock about 172.6% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Copart scores 74 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 36.6% operating margin and a 14.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. CPRT currently trades below its estimated intrinsic value and scores 74/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.